NMPA Approval

Venlafaxine Hydrochloride Sustained-release Tablets

Approval Number

国药准字H20233245

Company合肥立方制药股份有限公司

Registration Date

March 7, 2023

Drug Information

Generic Name

盐酸文拉法辛缓释片

Dosage Form

片剂

Strength

75mg（按C₁₇H₂₇NO₂计）

Drug Type

化学药品

Registration Date

March 7, 2023

Company Information

Applicant Company

Company Name合肥立方制药股份有限公司

Company Address

合肥市长江西路669号立方厂区

Manufacturing Company

Company Name合肥立方制药股份有限公司

Company Address

合肥市高新区文曲路446号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸文拉法辛缓释片 - NMPA 批准文号 | MedPath